The importance of recognizing sex differences in Alzheimer’s disease  

By: Christine Bahls

Here are some interesting articles on this topic.

Frontiers: Sex-differences in COPD: from biological mechanisms to therapeutic considerations

USC Dornsife: Discovery of vast sex differences in cellular activity has major implications for disease treatment

Science: Sex differences in kidney metabolism may reflect sex-dependent outcomes in human diabetic kidney disease

Nature: Reporting outcome comparisons by sex in oncology clinical trials

 

In honour of the World Alzheimer’s Awareness month consider supporting our work. Through your generous donations, sponsorships, and partnerships we can further our research into sex and gender precision medicine.

 Women’s Quota Campaign

Return Home

Make a Donation

We are here to transform medicine and healthcare towards precision medicine. Right now, there is a critical need for your support. Donate today and help us continue to study Sex and Gender differences impacting brain and mental diseases.

Health begins with human beings, individuals – men and women are different when it comes to brain and mental disease frequency, severity, symptomatology, risk factors and even response to treatments. Thanks to the gifts from supporters like you the scientific community is starting to take note. We have shown the world that in diseases like Alzheimer’s for instance, disease progression is faster in women than men and women show different levels of biomarkers.

Our goal is to clearly identify such differences in diseases, diagnostic, and treatments, as well as novel technologies, and leverage them for better solutions. We ask for better clinical outcomes, better care, and innovative artificial intelligence (AI)-based solutions. Sex and gender differences are the first steps towards precision medicine, which acknowledges the specific needs of each patient. Our ultimate ambition is the realisation of the Research Institute for Sex and Gender Precision Medicine.